Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122721902 | 12272190 | 2 | F | 20160409 | 20160720 | 20160415 | 20160720 | EXP | US-SAGENTPRD-2016-US-000007 | SAGENT | 74.00 | YR | M | Y | 96.00000 | KG | 20160720 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122721902 | 12272190 | 1 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 2 | C | PHENOL. | PHENOL | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 3 | C | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 4 | PS | Heparin Sodium Injection, MDV, 30 mL, 1000 u/mL | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | DOSE TITRATED | N | WH519N | 90808 | SOLUTION FOR INJECTION | |||||||
| 122721902 | 12272190 | 5 | SS | Heparin Sodium Injection, MDV, 30 mL, 1000 u/mL | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | DOSE TITRATED | N | WH506N | 90808 | SOLUTION FOR INJECTION | |||||||
| 122721902 | 12272190 | 6 | SS | Heparin Sodium Injection, MDV, 30 mL, 1000 u/mL | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | DOSE TITRATED | N | WH460N | 90808 | SOLUTION FOR INJECTION | |||||||
| 122721902 | 12272190 | 7 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 8 | C | Tamsulosin | TAMSULOSIN | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 9 | C | VALACYCLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 10 | C | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 13 | C | Docusate | DOCUSATE | 1 | 0 | ||||||||||||
| 122721902 | 12272190 | 14 | C | Apixaban | APIXABAN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122721902 | 12272190 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122721902 | 12272190 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122721902 | 12272190 | 4 | 20160409 | 20160409 | 0 | |
| 122721902 | 12272190 | 5 | 20160409 | 20160409 | 0 | |
| 122721902 | 12272190 | 6 | 20160409 | 20160409 | 0 |